Press release
Meningococcal Conjugate Vaccine Market Value set to reach industry expectations (2017-2023)
Meningococcal Conjugate Vaccine Market
The major factors that contribute to the growth of the meningococcal conjugate vaccine market include increasing prevalence of diseases caused by microorganisms such as Neisseria meningitides, improving healthcare infrastructure, development of quality vaccines at an affordable price, and growing awareness about meningococcal vaccination & associated immunization. However, high costs, adverse effects of vaccines, and stringent government regulations hamper the growth of the global meningococcal conjugate vaccine market. Development of combination vaccines and large numbers of mergers & acquisition strategies among key vendors are expected to propel the growth of the market in the near future.
Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4143
The global meningococcal conjugate vaccine market is segmented on the basis of composition, brand, end user, and region. On the basis of composition, the market is bifurcated into mono and combination vaccines. Based on brand, the market is segmented into Menactra, Menveo, NeisVac-C, Nimenrix, and others which include Meningitec, menAfriVac, Menjugate, and NmVac4-DT. On the basis of end user, the market is segmented into children, preteens or teens, and adults. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in this market include Sanofi Pasteur, Pfizer Inc., GlaxoSmithKline plc., Hualan Biological Engineering Inc., JN International Medical Corporation, Baxter International Inc., Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Biomed Pvt. Ltd., and Novartis AG.
Key Benefits
• The study provides an in-depth analysis of the global meningococcal conjugate vaccine market with current trends and future estimations to elucidate imminent investment pockets.
• The report provides information about the current and upcoming trends in the global meningococcal conjugate vaccine market from 2016 to 2023, which helps determine prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the global meningococcal conjugate vaccine market has been provided.
• Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
• Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global meningococcal conjugate vaccine market.
For More Info Visit @ https://www.alliedmarketresearch.com/meningococcal-conjugate-vaccine-market
Meningococcal Conjugate Vaccine Market Key Segments:
By Composition
• Mono Vaccines
• Combination Vaccines
By Brand
• Menactra
• Menveo
• NeisVac-C
• Nimenrix
• Others (Meningitec, menAfriVac, Menjugate, and NmVac4-DT)
By End User
• Children
• Preteens or Teens
• Adults
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Conjugate Vaccine Market Value set to reach industry expectations (2017-2023) here
News-ID: 1581340 • Views: …
More Releases from Allied Market Research
Action Figure Toys Market is likely to grow at a CAGR of 5.3% through 2031, reac …
The action figure toys market was valued at $9 billion in 2021, and is estimated to reach $15.3 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/17487
The reason for the popularity of action figure toys is that it is a highly competitive market. As a result, there are numerous companies that manufacture these toys, and each…
Low-Cost Airlines Market to Observe Highest Growth of USD 543.1 billion with Gro …
The global low cost airlines market was valued at $298.0 billion in 2023, and is projected to reach $543.1 billion by 2034, growing at a CAGR of 5.7% from 2024 to 2034
Request The Sample PDF of This Report: @ https://www.alliedmarketresearch.com/request-sample/4562
Low cost airlines, also known as budget or no-frills carriers, are airlines that offer low fares by minimizing traditional services and amenities. They typically use a single aircraft…
5G in Aviation Market Overview by Increasing Demands and Sales By 2021-2030
The global 5G in aviation market size was valued at $0.70 billion in 2020, and is projected to reach $4.68 billion by 2030, registering with a CAGR of 22.8% from 2021 to 2030.
The growth of the global 5G in aviation market is driven by growth in air passenger traffic across the globe, rise in inclination toward R&D activities for 5G network and related technology development, and changing aviation industry outlook.
Download…
Yerba Mate Market Current Trends, Future Prospects, and Competitive Landscape By …
The global yerba mate industry was generated $1.8 billion in 2022 and is anticipated to generate $2.9 billion by 2032, witnessing a CAGR of 5.2% from 2023 to 2032.
Yerba mate has strong cultural ties, especially in South America. As cultural diversity gains attention globally, there is an increasing interest in trying beverages with cultural significance. Yerba mate's unique cultural appeal contributes to its popularity among consumers seeking authentic and exotic…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
